QL Biopharma $72.77M Series C funding round
QL Biopharma $72.77M Series C funding round
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$145.5M
Top Valuation
-
QL Biopharma raised $72.8M in a Late Stage Venture round.
The round was led by OrbiMed.